Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis

Peptides Derived of Kunitz-Type Serine Protease Inhibitor as Potential Vaccine Against Experimental Schistosomiasis

Schistosomiasis is a significant public health problem in sub-Saharan Africa, China, Southeast Asia, and regions of South and Central America affecting about 189 million people. Kunitz-type serine protease inhibitors have been identified as important players in the interaction of other flatworm para...

Full description

Bibliographic Details
Main Authors: Juan Hernández-Goenaga, Julio López-Abán, Anna V. Protasio, Belén Vicente Santiago, Esther del Olmo, Magnolia Vanegas, Pedro Fernández-Soto, Manuel Alfonso Patarroyo, Antonio Muro
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-11-01
Series:Frontiers in Immunology
Subjects:
Schistosoma mansoni
helminth vaccines
kunitz-type proteins
synthetic peptide
immunomodulator AA0029
ADAD vaccination system
Online Access:https://www.frontiersin.org/article/10.3389/fimmu.2019.02498/full

Internet

https://www.frontiersin.org/article/10.3389/fimmu.2019.02498/full

Similar Items